30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Burkhardt Glen

Insider profile

Performance

Overall performance
1.8

Performance over holding periods
1.8
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Burkhardt Glen's trades of PhaseBio Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-05-24 2022-05-23 PlS Planned sale
60,749 -19.8%
462.01
US$2,876,297
60,749 -19.8% 462.01 US$2,876,297
2021-11-23 2021-11-19 PlS Planned sale
92,380 +20.7%
207.32
US$4,234,913
92,380 +20.7% 207.32 US$4,234,913
2021-05-24 2021-05-20 S Sale
91,500 +50.0%
263.16
US$2,256,258
91,500 +50.0% 263.16 US$2,256,258
2020-11-23 2020-11-23 S Sale
3,497 -100.0%
3.45
US$12,065
3,497 -100.0% 3.45 US$12,065